Using CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Zachary S Zumsteg, MD
Cedars-Sinai Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Cedars-Sinai Cancer at Beverly Hills (tho)
Beverly Hills, California, United States
David Hoffman, MDJeremy Lorber, MDKamalesh Sankhala, MDKevin Scher, MDLeland Green, MDRecruiting - Cedars Sinai Medical Center
Los Angeles, California, United States
Alain Mita, MDAllen Ho, MDEvan Walgama, MDJon Mallen-St. Clair, MDJulie Jang, MDJun Gong, MDRonald Natale, MDStephen Shiao, MDZachary S Zumsteg, MDRecruiting - Cs Cancer at Valley Oncology Medical Group
Tarzana, California, United States
Anirban Balmanoukian, MDBenjamin L King, MDJohnny K Chang, MDNatasha Banerjee, MDRobert S Reznik, MDRyan Ponec, MDRecruiting - Cs Cancer at the Hunt Cancer Center
Torrance, California, United States
Andrew Horodner, MDAndrew Schumacher, MDBryan Chang, MDDavid Chan, MDHugo Hool, MDRebecca Philipson, MDSwati Sikaria, MDSyed Jilani, MDThomas Lowe, MDThyra Endicott, MDUsama Mahmood, MDVanessa Dickey, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 12 May 2025
- Primary completion
- 30 Jun 2032
- Completion
- 30 Jun 2032
- Last update posted
- 8 May 2026
- Registered enrollment
- 50
- Registry id
- NCT06445114
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.